Balveen Kaur Solid Tumor Biology Program, James Comprehensive Cancer Center The Ohio State University Medical Center Biography Publications Institution JoVE Articles Balveen Kaur has not added a biography. If you are Balveen Kaur and would like to personalize this page please email our Author Liaison for assistance. Publications Genetic Validation of the Protein Arginine Methyltransferase PRMT5 As a Candidate Therapeutic Target in Glioblastoma Cancer Research. Mar, 2014 | Pubmed ID: 24453002 DNA Demethylating Agents Synergize with Oncolytic HSV1 Against Malignant Gliomas Clinical Cancer Research : an Official Journal of the American Association for Cancer Research. Nov, 2013 | Pubmed ID: 24056786 Thymoquinone Inhibits Autophagy and Induces Cathepsin-mediated, Caspase-independent Cell Death in Glioblastoma Cells PloS One. 2013 | Pubmed ID: 24039814 STAT3 Activation Promotes Oncolytic HSV1 Replication in Glioma Cells PloS One. 2013 | Pubmed ID: 23936533 Brain-specific Angiogenesis Inhibitor-1 Signaling, Regulation, and Enrichment in the Postsynaptic Density The Journal of Biological Chemistry. Aug, 2013 | Pubmed ID: 23782696 Systemic Delivery of SapC-DOPS Has Antiangiogenic and Antitumor Effects Against Glioblastoma Molecular Therapy : the Journal of the American Society of Gene Therapy. Aug, 2013 | Pubmed ID: 23732993 Cytomegalovirus Contributes to Glioblastoma in the Context of Tumor Suppressor Mutations Cancer Research. Jun, 2013 | Pubmed ID: 23729642 Gene Expression Profiling of the Anti-glioma Effect of Cilengitide SpringerPlus. Dec, 2013 | Pubmed ID: 23667810 How Can We Trick the Immune System into Overcoming the Detrimental Effects of Oncolytic Viral Therapy to Treat Glioblastoma? Expert Review of Neurotherapeutics. Apr, 2013 | Pubmed ID: 23545048 VEGF Blockade Enables Oncolytic Cancer Virotherapy in Part by Modulating Intratumoral Myeloid Cells Molecular Therapy : the Journal of the American Society of Gene Therapy. May, 2013 | Pubmed ID: 23481323 Effective Treatment of an Orthotopic Xenograft Model of Human Glioblastoma Using an EGFR-retargeted Oncolytic Herpes Simplex Virus Molecular Therapy : the Journal of the American Society of Gene Therapy. Mar, 2013 | Pubmed ID: 23070115 Bimodal Anti-glioma Mechanisms of Cilengitide Demonstrated by Novel Invasive Glioma Models Neuropathology : Official Journal of the Japanese Society of Neuropathology. Apr, 2013 | Pubmed ID: 22989076 NK Cells Impede Glioblastoma Virotherapy Through NKp30 and NKp46 Natural Cytotoxicity Receptors Nature Medicine. Dec, 2012 | Pubmed ID: 23178246 Anti-angiogenic Gene Therapy in the Treatment of Malignant Gliomas Neuroscience Letters. Oct, 2012 | Pubmed ID: 22906922 Extracellular Vesicles and Their Convergence with Viral Pathways Advances in Virology. 2012 | Pubmed ID: 22888349 Copper Chelation Enhances Antitumor Efficacy and Systemic Delivery of Oncolytic HSV Clinical Cancer Research : an Official Journal of the American Association for Cancer Research. Sep, 2012 | Pubmed ID: 22753591 MicroRNAs/TP53 Feedback Circuitry in Glioblastoma Multiforme Proceedings of the National Academy of Sciences of the United States of America. Apr, 2012 | Pubmed ID: 22431589 The HDAC Inhibitor Valproic Acid Lessens NK Cell Action Against Oncolytic Virus-infected Glioblastoma Cells with Inhibition of STAT5/T-BET Signaling and IFNγ Generation Journal of Virology. Feb, 2012 | Pubmed ID: 22318143 Deciphering the Multifaceted Relationship Between Oncolytic Viruses and Natural Killer Cells Advances in Virology. 2012 | Pubmed ID: 22312364 Extracellular Matrix Protein CCN1 Limits Oncolytic Efficacy in Glioma Cancer Research. Mar, 2012 | Pubmed ID: 22282654 Antitumor Efficacy of 34.5ENVE: a Transcriptionally Retargeted and "Vstat120"-expressing Oncolytic Virus Molecular Therapy : the Journal of the American Society of Gene Therapy. Feb, 2012 | Pubmed ID: 22031239 Oncolytic HSV-1 Virotherapy: Clinical Experience and Opportunities for Progress Current Pharmaceutical Biotechnology. Jul, 2012 | Pubmed ID: 21740359 Phase IB Study of Gene-mediated Cytotoxic Immunotherapy Adjuvant to Up-front Surgery and Intensive Timing Radiation for Malignant Glioma Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. Sep, 2011 | Pubmed ID: 21844505 Indirubins Decrease Glioma Invasion by Blocking Migratory Phenotypes in Both the Tumor and Stromal Endothelial Cell Compartments Cancer Research. Aug, 2011 | Pubmed ID: 21697283 Chondroitinase ABC I-mediated Enhancement of Oncolytic Virus Spread and Antitumor Efficacy Clinical Cancer Research : an Official Journal of the American Association for Cancer Research. Mar, 2011 | Pubmed ID: 21177410 Impact of Tumor Microenvironment on Oncolytic Viral Therapy Cytokine & Growth Factor Reviews. Apr-Jun, 2010 | Pubmed ID: 20399700 Directing Systemic Oncolytic Viral Delivery to Tumors Via Carrier Cells Cytokine & Growth Factor Reviews. Apr-Jun, 2010 | Pubmed ID: 20226717 Histidine-rich Glycoprotein Modulates the Anti-angiogenic Effects of Vasculostatin The American Journal of Pathology. Apr, 2010 | Pubmed ID: 20167858 Enhanced Antitumor Efficacy of Vasculostatin (Vstat120) Expressing Oncolytic HSV-1 Molecular Therapy : the Journal of the American Society of Gene Therapy. Feb, 2010 | Pubmed ID: 19844198 "Buy One Get One Free": Armed Viruses for the Treatment of Cancer Cells and Their Microenvironment Current Gene Therapy. Oct, 2009 | Pubmed ID: 19860649 Pharmacologic and Chemical Adjuvants in Tumor Virotherapy Chemical Reviews. Jul, 2009 | Pubmed ID: 19462957 Rat Brain Tumor Models in Experimental Neuro-oncology: the C6, 9L, T9, RG2, F98, BT4C, RT-2 and CNS-1 Gliomas Journal of Neuro-oncology. Sep, 2009 | Pubmed ID: 19381449 Vasculostatin Inhibits Intracranial Glioma Growth and Negatively Regulates in Vivo Angiogenesis Through a CD36-dependent Mechanism Cancer Research. Feb, 2009 | Pubmed ID: 19176395 Advances in Oncolytic Virus Therapy for Glioma Recent Patents on CNS Drug Discovery. Jan, 2009 | Pubmed ID: 19149710 Oncolytic HSV-1 Infection of Tumors Induces Angiogenesis and Upregulates CYR61 Molecular Therapy : the Journal of the American Society of Gene Therapy. Aug, 2008 | Pubmed ID: 18545226 Effect of Tumor Microenvironment Modulation on the Efficacy of Oncolytic Virus Therapy Journal of the National Cancer Institute. Dec, 2007 | Pubmed ID: 18042934 Depletion of Peripheral Macrophages and Brain Microglia Increases Brain Tumor Titers of Oncolytic Viruses Cancer Research. Oct, 2007 | Pubmed ID: 17909049 Oncolytic Viruses Driven by Tumor-specific Promoters Current Cancer Drug Targets. Mar, 2007 | Pubmed ID: 17346110 Personalizing Oncolytic Virotherapy? Molecular Therapy : the Journal of the American Society of Gene Therapy. Jan, 2007 | Pubmed ID: 17164767 Oncolytic Viruses: Extreme Treatment for an Extreme Disease Future Microbiology. Dec, 2006 | Pubmed ID: 17661625 Cyclophosphamide Increases Transgene Expression Mediated by an Oncolytic Adenovirus in Glioma-bearing Mice Monitored by Bioluminescence Imaging Molecular Therapy : the Journal of the American Society of Gene Therapy. Dec, 2006 | Pubmed ID: 16996314 Cyclophosphamide Enhances Glioma Virotherapy by Inhibiting Innate Immune Responses Proceedings of the National Academy of Sciences of the United States of America. Aug, 2006 | Pubmed ID: 16908838 Gene Therapeutics: the Future of Brain Tumor Therapy? Expert Review of Anticancer Therapy. Jul, 2006 | Pubmed ID: 16831077 Hypoxia and the Hypoxia-inducible-factor Pathway in Glioma Growth and Angiogenesis Neuro-oncology. Apr, 2005 | Pubmed ID: 15831232 Vasculostatin, a Proteolytic Fragment of Brain Angiogenesis Inhibitor 1, is an Antiangiogenic and Antitumorigenic Factor Oncogene. May, 2005 | Pubmed ID: 15782143 Genetic and Hypoxic Regulation of Angiogenesis in Gliomas Journal of Neuro-oncology. Nov, 2004 | Pubmed ID: 15674480 Cancer Therapy with a Replicating Oncolytic Adenovirus Targeting the Hypoxic Microenvironment of Tumors Clinical Cancer Research : an Official Journal of the American Association for Cancer Research. Dec, 2004 | Pubmed ID: 15623644 Pseudopalisades in Glioblastoma Are Hypoxic, Express Extracellular Matrix Proteases, and Are Formed by an Actively Migrating Cell Population Cancer Research. Feb, 2004 | Pubmed ID: 14871821 Brain Angiogenesis Inhibitor 1 is Differentially Expressed in Normal Brain and Glioblastoma Independently of P53 Expression The American Journal of Pathology. Jan, 2003 | Pubmed ID: 12507886 Genetic Modulation of Hypoxia Induced Gene Expression and Angiogenesis: Relevance to Brain Tumors Frontiers in Bioscience : a Journal and Virtual Library. Jan, 2003 | Pubmed ID: 12456339 Initiation of Human Astrocytoma by Clonal Evolution of Cells with Progressive Loss of P53 Functions in a Patient with a 283H TP53 Germ-line Mutation: Evidence for a Precursor Lesion Cancer Research. May, 2002 | Pubmed ID: 12019170 Geldanamycin Induces Degradation of Hypoxia-inducible Factor 1alpha Protein Via the Proteosome Pathway in Prostate Cancer Cells Cancer Research. May, 2002 | Pubmed ID: 11980636 Genetic and Biologic Progression in Astrocytomas and Their Relation to Angiogenic Dysregulation Advances in Anatomic Pathology. Jan, 2002 | Pubmed ID: 11756757 In Vivo Optical Imaging of Brain Tumors and Arthritis Using Fluorescent SapC-DOPS Nanovesicles Zhengtao Chu1,2, Kathleen LaSance3, Victor Blanco1, Chang-Hyuk Kwon5,6, Balveen Kaur5,6, Malinda Frederick4, Sherry Thornton4, Lisa Lemen3, Xiaoyang Qi1,2 1Division of Hematology-Oncology, Department of Internal Medicine, University of Cincinnati College of Medicine, 2Division of Human Genetics, University of Cincinnati College of Medicine, 3Department of Radiology, University of Cincinnati College of Medicine, 4Division of Rheumatology, Cincinnati Children's Hospital Medical Center, University of Cincinnati College of Medicine, 5Solid Tumor Biology Program, James Comprehensive Cancer Center, The Ohio State University Medical Center, 6Department of Neurological Surgery, James Comprehensive Cancer Center, The Ohio State University Medical Center JoVE 51187 Médecine
In Vivo Optical Imaging of Brain Tumors and Arthritis Using Fluorescent SapC-DOPS Nanovesicles Zhengtao Chu1,2, Kathleen LaSance3, Victor Blanco1, Chang-Hyuk Kwon5,6, Balveen Kaur5,6, Malinda Frederick4, Sherry Thornton4, Lisa Lemen3, Xiaoyang Qi1,2 1Division of Hematology-Oncology, Department of Internal Medicine, University of Cincinnati College of Medicine, 2Division of Human Genetics, University of Cincinnati College of Medicine, 3Department of Radiology, University of Cincinnati College of Medicine, 4Division of Rheumatology, Cincinnati Children's Hospital Medical Center, University of Cincinnati College of Medicine, 5Solid Tumor Biology Program, James Comprehensive Cancer Center, The Ohio State University Medical Center, 6Department of Neurological Surgery, James Comprehensive Cancer Center, The Ohio State University Medical Center JoVE 51187 Médecine